Previous studies have shown that the high mortality caused by viruses such as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus primarily results from …

In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged,
causing a global pandemic called COVID-19. Currently, there is no definitive treatment for …

The outbreak of the novel coronavirus disease 2019 (COVID-19) has emerged as one of the
biggest global health threats worldwide. As of October 2020, more than 44 million confirmed …

The coronavirus disease 2019 (COVID-19) pandemic has presented a serious public health
threat, resulting in more than 600 million infections worldwide and 6 million fatalities. 1 The …

Acute respiratory viral infections (ARVI) are the most common illnesses worldwide. In some
instances, mild cases of ARVI progress to hyperinflammatory responses, which are …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus
responsible for the clinical syndrome coronavirus disease 2019 (COVID-19). This virus was …

The chemokine CXCL8, also known as the neutrophil chemotactic factor, plays a crucial role
in mediating inflammatory responses and managing cellular immune reactions during viral …

Cytokine storm (CS), an excessive release of proinflammatory cytokines upon overactivation
of the innate immune system, came recently to the focus of interest because of its role in the …

Background Patients with myasthenia gravis (MG) are potentially prone for a severe COVID-
19 course, but there are limited real-world data available on the risk associated with COVID …

A major barrier to human immunodeficiency virus (HIV-1) cure is the latent viral reservoir,
which persists despite antiretroviral therapy (ART), including across the non-dividing …